InVivo prices equity offering; shares off 9% premarket

• InVivo Therapeutics (NASDAQ:NVIV) is down 9% premarket on light volume in response to its public offering of 3,733,333 units at $7.50 per unit. Each unit consists of one share of common stock and 1/2 of a warrant to buy one share of common at $10.00 per share.
• Underwriters over-allotment is an additional 560K shares of stock and/or warrants to purchase up to 280K shares. Closing date is March 18.